Clinical trial
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal…
NCT00383266 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00383266 |
|---|---|
| Title | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer |
| Official title | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Neoplasms |
| Intervention type | Drug |
| Interventions | Pemetrexed, Carboplatin |
| Enrollment | 9 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Oct 3, 2006 |
| Last update posted | Jan 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: